Loading...

OGN ORGANON & CO Management Changes 8-K Filing

RGNN

GN

ORGANON & CO

(OGN)

2025 8-K

Show Summary

Summary

Amendments to Stock Plans

New Product Launches

Financial Statements

Board Appointment

Earnings Announcement

Management Change

Board Restructuring

Board Resignation

FDA Review Extension

Earnings Report

Merger Agreement

Earnings Release

Annual Meeting Voting Results

Private Offering of Notes

Earnings Release

Earnings Reports

Departure of Director

Earnings Reports

Earnings Reports

Earnings Release

Earnings Reports

External Links:

Organon & Co. announced that Susanne Fiedler has stepped down as Chief Commercial Officer, effective January 15, 2025, but will remain as a senior advisor until approximately April 30, 2025.

AI Assistant

ORGANON & CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.